It is demonstrated that PACAP exerts neuroprotective effects through multiple mechanisms in Alzheimer's disease patients and mouse models (Vaudry et al., 2004; Rat et al., 2011). This evidence concerns the gene ADCYAP1 and early-onset autosomal dominant Alzheimer disease.